產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-BP1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-BP1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-BP1
Cat. Number:
Anti-BP1抗體KL-12307R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Aminopeptidase A, also Anti-BP1抗體designated APA, gp160 human kidney differentiation antigen, glutamyl aminopeptidase, or enpep, is a differentiation-related kidney glycoprotein. As a cell surface, zinc-dependent metalloprotease, Aminopepti-dase A specifically cleaves amino-terminal acidic residues from peptide substrates such as Angiotensin II. APA is expressed on the surface of epithelial cells of the glomerulus and proximal tubule cells of the human nephron, where it may mediate the constitutive trafficking of Glut4-containing vesicles. These Glut4-containing vesicles are tissue-specific secretory-like microsomal structures that mediate insulin-dependent translocation of GLUT4 to the cell surface in fat and muscle cells. Mutations in the gp160/APA gene, including loss of protein expression or enzymaticAnti-BP1抗體 activity, occur in 20% of primary clear cell renal carcinomas.
Also known as:
Aminopeptidase A; AMPE_HUMAN; AP-A; APA; CD249; CD 249; Differentiation antigen gp160; EAP; EC 3.4.11.7; ENPEP; Anti-BP1抗體Glutamyl aminopeptidase; Gp160; Ly51; Ly51/6C3 antigen.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Aminopeptidase A.
●
Predicted Molecular Weight: 109kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-BP1抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-BP1抗體
Optimal working dilutions must be determined by the end user.
kl699Ra01 環(huán)加氧酶2(PTGS2)多克隆抗體 Polyclonal Antibody to Prostaglandin Endoperoxide Synthase 2 (PTGS2)
kl700Hu01 棕櫚酰化膜蛋白6(MPP6)多克隆抗體 Polyclonal Antibody to Membrane Protein, klmitoylated 6 (MPP6)
kl702Pl01 硫氧化還原蛋白(Trx)多克隆抗體 Polyclonal Antibody to Thioredoxin (Trx)
kl703Hu01 硫氧還蛋白還原酶1(TrxR1)多克隆抗體 Polyclonal Antibody to Thioredoxin Reductase 1 (TrxR1)
kl703Mu01 硫氧還蛋白還原酶1(TrxR1)多克隆抗體 Polyclonal Antibody to Thioredoxin Reductase 1 (TrxR1)
kl704Po01 載脂蛋白E(APOE)多克隆抗體 Polyclonal Antibody to Apolipoprotein E (APOE)
kl704Rb51 載脂蛋白E(APOE)多克隆抗體 Polyclonal Antibody to Apolipoprotein E (APOE)
kl706Hu01 內(nèi)臟脂肪特異性絲氨酸蛋白酶抑制因子(Vaspin)多克隆抗體 Polyclonal Antibody to Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
kl706Mu01 內(nèi)臟脂肪特異性絲氨酸蛋白酶抑制因子(Vaspin)多克隆抗體 Polyclonal Antibody to Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
kl706Ra01 內(nèi)臟脂肪特異性絲氨酸蛋白酶抑制因子(Vaspin)多克隆抗體 Polyclonal Antibody to Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
kl708Hu01 δ-促睡眠肽(δSIP)多克隆抗體 Polyclonal Antibody to Delta-Sleep Inducing Peptide (dSIP)
kl709Hu01 Toll樣受體9(TLR9)多克隆抗體 Polyclonal Antibody to Toll Like Receptor 9 (TLR9)
kl711Hu01 肝素酶(HPA)多克隆抗體 Polyclonal Antibody to Heklanase (HPA)
kl711Mu01 肝素酶(HPA)多克隆抗體 Polyclonal Antibody to Heklanase (HPA)
kl712Mu01 鈉/鉀離子轉(zhuǎn)運(yùn)ATP酶β3肽(ATP1β3)多克隆抗體 Polyclonal Antibody to ATkle, Na+/K+ Transporting Beta 3 Polypeptide (ATP1b3)
kl713Hu01 CCAAT增強(qiáng)子結(jié)合蛋白β(CEBPβ)多克隆抗體 Polyclonal Antibody to CCAAT/Enhancer Binding Protein Beta (CEBPb)
